Skip to content

APOTHEEK TOMBAL

Active
Private limited companyfounded 2012active for 14 yearsGrote Markt 72, 2500 Lier, BelgiumKBO/BCE: BE 0848.202.939
Summary

APOTHEEK TOMBAL has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €304,355 and a net result of €42,922. Equity has been growing by about 22% per year since 2018. Its solvency ranks better than 87% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-08-2012 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.212.016.902 2500 Lier, since 01-10-2012
Financial year end
31 December
Peppol
Reachable since 01-05-2025

Board and ownership

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€97,644
▼ 35.3%
Turnover
≈ €480,000
estimated
Profit
€42,922
▼ 51.8%
Equity
€304,355
▲ 7.8%
Total assets
€396,952
▼ 4.4%
Employees on 31-12-2025
1
Score breakdownraises riskSize: 1.1 FTE, total assets €396,952lowers riskLiquidity: current ratio 4.33, cash €128,944Equity €304,355 (76.7% of total assets)Founded in 2012Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 78% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 100+7
equity 76.7% of total assets
Liquidity 83+2
short-term debt 22.6% · cash 32.5%
Profitability 82-14
return on assets 10.8%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,278 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: 0.1%● unchanged vs 07-2026highest value 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: 0.1%● unchanged vs 09-2026highest value 11-2026: 0.1%● unchanged vs 10-2026highest value
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.33 (3.14 in 2024), above the usual 1.5. Short-term debt is 22.6% and cash 32.5% of total assets. 23.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 86% on liquidity, 75% on profitability and 57% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 4.33, cash €128,944
NBB · annual accounts
lowers risk · Equity €304,355 (76.7% of total assets)
NBB · annual accounts
lowers risk · Founded in 2012
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Size: 1.1 FTE, total assets €396,952
Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
43 days early
2024
7 days early
2023
19 days early
2022
14 days early
2021
19 days early
2020
18 days early
2019
15 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 86% of companies in retail tradesector median 36.6% · 12,781 companies 76.7% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €42,922 8 years View

Recent changes

  1. · Gazette deed Amendment of the articles · Legal-form change · Resignations & appointmentsChange of role: TOMBAL Inge Ruth Marleen, from manager to director · 1,860 shares · Director discharge: TOMBAL Inge Ruth Marleen
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as APOTHEEK TOMBAL: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €328,000 and €420,000, founded between 2009 and 2013.

CompanyTotal assetsGross margin
APOTHEEK TOMBAL Lier€396,952€97,644
Pharmacie Dedobbeleer sprl Sombreffe€372,396€111,349
DETIPHAR Colfontaine€356,249€88,159
PHARMACIE DALNE Schaarbeek€419,660€93,420
APOTHEEK PEETERS Tienen€391,521€83,634
Apotheek Werchter Rotselaar€402,771€129,592
APOTHEEK BOGAERTS Gent€328,281€110,100
Full comparison

Key facts about APOTHEEK TOMBAL

What is the company number of APOTHEEK TOMBAL?
The company number of APOTHEEK TOMBAL is 0848.202.939. The VAT number is the same number with BE in front: BE 0848.202.939.
Where is APOTHEEK TOMBAL based?
The registered office is at Grote Markt 72, 2500 Lier.Company details
What does APOTHEEK TOMBAL do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK TOMBAL?
The legal form of APOTHEEK TOMBAL is Private limited company (BV).
When was APOTHEEK TOMBAL founded?
APOTHEEK TOMBAL was founded on 20-08-2012.
Is APOTHEEK TOMBAL still active?
Yes, APOTHEEK TOMBAL is an active enterprise in the KBO register.
How many employees does APOTHEEK TOMBAL have?
APOTHEEK TOMBAL had an average of 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK TOMBAL fall under?
In its 2025 annual accounts, APOTHEEK TOMBAL states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of APOTHEEK TOMBAL?
The turnover in financial year 2025 is ≈ €480,000. This figure is estimated from the gross margin of €97,644 and 73 comparable companies (NACE 477). It probably lies between €230,000 and €690,000.
Is APOTHEEK TOMBAL profitable?
In financial year 2025, APOTHEEK TOMBAL made a profit of €42,922.
Where can I find the annual accounts of APOTHEEK TOMBAL?
APOTHEEK TOMBAL filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK TOMBAL due?
APOTHEEK TOMBAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.